|
[Related PubMed/MEDLINE]
Total Number of Papers: 133
|
|
|
| |
|
[Display Entries]
|
|
>> all entries
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2022 |
ABCA4 c.859-25A>G, a Frequent Palestinian Founder Mutation Affecting the Intron 7 Branchpoint, Is Associated With Early-Onset Stargardt Disease. |
CRD |
| 2 |
2022 |
Choroidal vascularity index in eyes with central macular atrophy secondary to age-related macular degeneration and Stargardt disease. |
AMD, CVI, MA, TCA |
| 3 |
2021 |
Clinical and Genetic Spectrum of Stargardt Disease in Argentinean Patients. |
--- |
| 4 |
2021 |
High-resolution images in macular disorders. |
AO, CSC, FAF, OCT, RP |
| 5 |
2021 |
Microvascular and metabolic alterations in retinitis pigmentosa and Stargardt disease. |
no-ME-RP, OCTA, RO, RP |
| 6 |
2021 |
Motion-Based Acuity Task: Full Visual Field Measurement of Shape and Motion Perception. |
RDKs, RP |
| 7 |
2021 |
Non-syndromic inherited retinal diseases in Poland: Genes, mutations, and phenotypes. |
IRDs, NGS, RP |
| 8 |
2021 |
Outer nuclear layer relevance in visual function correlated to quantitative enface OCT parameters in Stargardt disease. |
BCVA, C-ONL-T, CR-T, OCT, RPE |
| 9 |
2021 |
Retinal Vascular Abnormalities in Different Types of Inherited Retinal Dystrophies Assessed by Optical Coherence Tomography Angiography. |
CRD, IRDs, RP, SCP and DCP, VDs |
| 10 |
2021 |
Targeted next-generation sequencing identifies ABCA4 mutations in Chinese families with childhood-onset and adult-onset Stargardt disease. |
NGS |
| 11 |
2020 |
Automated classification of normal and Stargardt disease optical coherence tomography images using deep learning. |
CNN, JSS, OCT |
| 12 |
2020 |
Deep Learning-Based Classification of Inherited Retinal Diseases Using Fundus Autofluorescence. |
BD, CNN, FAF, IRD, PRC-AUC, RP |
| 13 |
2020 |
Exome sequencing analysis identifies novel homozygous mutation in ABCA4 in a Chinese family with Stargardt disease. |
WES |
| 14 |
2020 |
Formulation and efficacy of ECO/pRHO-ABCA4-SV40 nanoparticles for nonviral gene therapy of Stargardt disease in a mouse model. |
--- |
| 15 |
2020 |
Living with Stargardt disease: insights from patients and their parents. |
--- |
| 16 |
2020 |
Novel variants associated with Stargardt disease in Chinese patients. |
NGS, UTRs |
| 17 |
2020 |
Progressive Choriocapillaris Impairment in ABCA4 Maculopathy Is Secondary to Retinal Pigment Epithelium Atrophy. |
CC, OCTA, RPE, SW-AF |
| 18 |
2020 |
Retinal Glial and Choroidal Vascular Pathology in Donors Clinically Diagnosed With Stargardt Disease. |
FFB |
| 19 |
2020 |
Saccadic movements assessment in eccentric fixation: A study in patients with Stargardt disease. |
--- |
| 20 |
2020 |
Simultaneous expression of two pathogenic genes in four Chinese patients affected with inherited retinal dystrophy. |
adRP, arRP, HEDEP, IRDs, RP |
| 21 |
2020 |
Systemic administration of the di-apocarotenoid norbixin (BIO201) is neuroprotective, preserves photoreceptor function and inhibits A2E and lipofuscin accumulation in animal models of age-related macular degeneration and Stargardt disease. |
AMD, BLD, RPE |
| 22 |
2020 |
Thinner temporal peripapillary retinal nerve fibre layer in Stargardt disease detected by optical coherence tomography. |
OCT, RNFL |
| 23 |
2020 |
[Morphological and functional indicators of retinal pigment epithelium and photoreceptor apparatus in inherited retinal diseases]. |
AF, CP, CRD, EOG, G-ERG, IRD, OCT, PR, RP, RPE |
| 24 |
2019 |
An ABCA4 loss-of-function mutation causes a canine form of Stargardt disease. |
ABCA4, RPE |
| 25 |
2019 |
Application of targeted exome and whole-exome sequencing for Chinese families with Stargardt disease. |
--- |
| 26 |
2019 |
Characterisation of vascular changes in different stages of Stargardt disease using double swept-source optical coherence tomography angiography. |
CC, FAZ, ORCC, SCP/DCP |
| 27 |
2019 |
Choroidal Patterns in Stargardt Disease: Correlations with Visual Acuity and Disease Progression. |
BCVA, OCT, OCTA |
| 28 |
2019 |
Correlation between Choriocapillaris Density and Retinal Sensitivity in Stargardt Disease. |
CA, CC, DA, MP, NA, PPCA, SS WF OCTA |
| 29 |
2019 |
Correlation of Outer Retinal Degeneration and Choriocapillaris Loss in Stargardt Disease Using En Face Optical Coherence Tomography and Optical Coherence Tomography Angiography. |
CC, CCVD, IS/OS, OCTA, RPE |
| 30 |
2019 |
Fluorescence Lifetime Patterns of Retinal Pigment Epithelium Atrophy in Patients with Stargardt Disease and Age-Related Macular Degeneration. |
AMD, RPE |
| 31 |
2019 |
Genetic Spectrum of ABCA4-Associated Retinal Degeneration in Poland. |
ABCA4, CRD, IRDs, MIPs, RFLP, RP |
| 32 |
2019 |
Genotypic profile and phenotype correlations of ABCA4-associated retinopathy in Koreans. |
ABCA4-RD, CRD, IRDs, RP |
| 33 |
2019 |
Impact of segmentation density on spectral domain optical coherence tomography assessment in Stargardt disease. |
ONL, OS, ProgStar, RPE, SD-OCT |
| 34 |
2019 |
Macular hyperpigmentary changes in ABCA4-Stargardt disease. |
AMD, FAF, ffERG, VA |
| 35 |
2019 |
Multimodal evaluation of central and peripheral alterations in Stargardt disease: a pilot study. |
OCT, OCTA, UWF |
| 36 |
2019 |
Non-viral Gene Therapy for Stargardt Disease with ECO/pRHO-ABCA4 Self-Assembled Nanoparticles. |
WT |
| 37 |
2019 |
OCTA-Based Identification of Different Vascular Patterns in Stargardt Disease. |
CMT, HF, OCT, OCTA, VD, VR, VT |
| 38 |
2019 |
Perceptual learning in patients with Stargardt disease. |
--- |
| 39 |
2018 |
CFH Y402H polymorphism in Italian patients with age-related macular degeneration, retinitis pigmentosa, and Stargardt disease. |
AMD, RP |
| 40 |
2018 |
Clinical and Genetic Characteristics Analysis of Korean Patients with Stargardt Disease Using Targeted Exome Sequencing. |
ABCA4, ELOVL4, PROM1 |
| 41 |
2018 |
Contrast sensitivity deficits in patients with mutation-proven inherited retinal degenerations. |
CS, IRD, QCSF, RCD, SD-OCT |
| 42 |
2018 |
EDI OCT evaluation of choroidal thickness in Stargardt disease. |
CT |
| 43 |
2018 |
Hyperreflective foci in Stargardt disease: 1-year follow-up. |
HF |
| 44 |
2018 |
Stargardt Disease. |
FAF, hyperAF |
| 45 |
2018 |
Stargardt Phenotype Associated With Two ELOVL4 Promoter Variants and ELOVL4 Downregulation: New Possible Perspective to Etiopathogenesis? |
ELOVL4, VLC-PUFA |
| 46 |
2018 |
Treatments for dry age-related macular degeneration and Stargardt disease: a systematic review. |
AMD, EME, HTA, VA |
| 47 |
2017 |
A Novel ABCA4 Mutation Associated with a Late-Onset Stargardt Disease Phenotype: A Hypomorphic Allele? |
--- |
| 48 |
2017 |
CHOROIDAL THICKNESS IN PATIENTS WITH STARGARDT DISEASE. |
CT, mfERG |
| 49 |
2017 |
Comparative analysis of autofluorescence and OCT angiography in Stargardt disease. |
CC, FAF, OCTA, RPE |
| 50 |
2017 |
Functional changes at the preferred retinal locus in subjects with bilateral central vision loss. |
AMD, BCEA, CVL, MSs, PRL |
| 51 |
2017 |
Morpho-functional analysis of Stargardt Disease for reading. |
BCVA, FAF, OCT |
| 52 |
2017 |
Novel compound heterozygous mutations in ABCA4 in a Chinese pedigree with Stargardt disease. |
--- |
| 53 |
2017 |
Optical Coherence Tomography Angiography Findings in Stargardt Disease. |
CC, DCP, ILM, IPL, mfERG, MT, OCTA, PERG, SCP, VD |
| 54 |
2017 |
Peripheral Visual Fields in ABCA4 Stargardt Disease and Correlation With Disease Extent on Ultra-widefield Fundus Autofluorescence. |
ffERG, UWF-FAF, VA |
| 55 |
2017 |
Quantifying the Rate of Ellipsoid Zone Loss in Stargardt Disease. |
EZ, FAF, ICC, OCT, RPE, SD-OCT |
| 56 |
2017 |
Reading Ability and Quality of Life in Stargardt Disease. |
ETDRS, VRQoL |
| 57 |
2017 |
Reading Performance Improvements in Patients with Central Vision Loss without Age-Related Macular Degeneration after Undergoing Personalized Rehabilitation Training. |
AFVD, CVL, MMD, QoL, RRP, VAs |
| 58 |
2017 |
Reliability and Repeatability of Cone Density Measurements in Patients With Stargardt Disease and RPGR-Associated Retinopathy. |
AOSLO, RPGR |
| 59 |
2017 |
STARGARDT DISEASE: Beyond Flecks and Atrophy. |
BrM, EZ |
| 60 |
2017 |
The Epidemiology of Stargardt Disease in the United Kingdom. |
BOSU |
| 61 |
2017 |
Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing. |
BMD, IRDs, LCA, NGS, RP, USH |
| 62 |
2017 |
[Contribution of multimodal imaging in the various stages of Stargardt disease]. |
FA, FAF, ICGA, RPE, SD-OCT |
| 63 |
2016 |
Analysis of ELOVL4 and PRPH2 genes in Turkish Stargardt disease patients. |
--- |
| 64 |
2016 |
Dark Atrophy: An Optical Coherence Tomography Angiography Study. |
AMD, EDI-OCT, FA, FAF, GA, ICGA, OCTA, RPE |
| 65 |
2016 |
Dietary profile of patients with Stargardt's disease and Retinitis Pigmentosa: is there a role for a nutritional approach? |
RP |
| 66 |
2016 |
Fluorescence Lifetime Imaging in Stargardt Disease: Potential Marker for Disease Progression. |
FLIO |
| 67 |
2016 |
Focal Choroidal Excavation in Retinal Dystrophies. |
FCE, RP |
| 68 |
2016 |
Test-Retest Variability of Functional and Structural Parameters in Patients with Stargardt Disease Participating in the SAR422459 Gene Therapy Trial. |
BCVA, CI, ETDRS, HOV, RC, SD-OCT, SKP, SVF |
| 69 |
2015 |
Cerebral Involvement in Stargardt's Disease: A VBM and TBSS Study. |
BCVA, DTI, ERG, GM, OCT, T1W, TBSS, VBM, WM |
| 70 |
2015 |
Choroidal Thickness in Eyes With Central Geographic Atrophy Secondary to Stargardt Disease and Age-Related Macular Degeneration. |
AMD, CT, FAF, GA, RPD, SD |
| 71 |
2015 |
Identification of Genetic Defects in 33 Probands with Stargardt Disease by WES-Based Bioinformatics Gene Panel Analysis. |
--- |
| 72 |
2015 |
Identification of Novel Mutations in ABCA4 Gene: Clinical and Genetic Analysis of Indian Patients with Stargardt Disease. |
--- |
| 73 |
2015 |
[The molecular genetic and clinical findings in two probands with Stargardt disease]. |
SD-OCT |
| 74 |
2014 |
Association between genotype and phenotype in families with mutations in the ABCA4 gene. |
ABCA4, arRP, CRD, ff-ERG, mERG, OCT |
| 75 |
2014 |
Causes and consequences of inherited cone disorders. |
ACHM, CDs, COD, CRD |
| 76 |
2014 |
Clinical and molecular characteristics of childhood-onset Stargardt disease. |
SD-OCT |
| 77 |
2014 |
Efficient gene delivery to the cone-enriched pig retina by dual AAV vectors. |
AAV, IRDs |
| 78 |
2014 |
Molecular diagnosis of putative Stargardt disease by capture next generation sequencing. |
CNGS |
| 79 |
2014 |
Multifunctional PEG retinylamine conjugate provides prolonged protection against retinal degeneration in mice. |
AMD, GFL, PEG |
| 80 |
2013 |
Biofeedback rehabilitation of eccentric fixation in patients with Stargardt disease. |
BCEA, BCVA, BF |
| 81 |
2013 |
Characterization of stargardt disease using polarization-sensitive optical coherence tomography and fundus autofluorescence imaging. |
FAF, PS-OCT |
| 82 |
2013 |
Effective delivery of large genes to the retina by dual AAV vectors. |
AAV |
| 83 |
2013 |
Phenotype/genotype correlation in a case series of Stargardt's patients identifies novel mutations in the ABCA4 gene. |
BCVA |
| 84 |
2013 |
Subretinal Fibrosis in Stargardt's Disease with Fundus Flavimaculatus and ABCA4 Gene Mutation. |
FFM |
| 85 |
2012 |
Correlation between photoreceptor layer integrity and visual function in patients with Stargardt disease: implications for gene therapy. |
IS/OS |
| 86 |
2012 |
Functional Analysis of Retinal Flecks in Stargardt Disease. |
FAF, RPE, SD-OCT |
| 87 |
2012 |
Molecular diagnosis of putative Stargardt Disease probands by exome sequencing. |
WES |
| 88 |
2012 |
The dark atrophy with indocyanine green angiography in Stargardt disease. |
FA, ICGA, SD-OCT |
| 89 |
2011 |
Cone photoreceptor abnormalities correlate with vision loss in patients with Stargardt disease. |
AF, AOSLO |
| 90 |
2011 |
Transition zones between healthy and diseased retina in choroideremia (CHM) and Stargardt disease (STGD) as compared to retinitis pigmentosa (RP). |
CHM, Fd, OR, OS, RP, TZ |
| 91 |
2010 |
DHA supplementation for late onset Stargardt disease: NAT-3 study. |
BCVA, DHA, LE, mfERG, RE |
| 92 |
2010 |
In vivo visualization of photoreceptor layer and lipofuscin accumulation in stargardt's disease and fundus flavimaculatus by high resolution spectral-domain optical coherence tomography. |
BCVA, FFM, HD-OCT, IS, OS, PR, RPE, VM |
| 93 |
2010 |
Inhibition of the visual cycle by A2E through direct interaction with RPE65 and implications in Stargardt disease. |
LRAT, RPE |
| 94 |
2009 |
Comparison of high-resolution melting analysis with denaturing high-performance liquid chromatography for mutation scanning in the ABCA4 gene. |
arCRD, arRP, DHPLC, HRM |
| 95 |
2009 |
Lipofuscin and autofluorescence metrics in progressive STGD. |
AF, FDAF, FIAF, GA |
| 96 |
2009 |
Novel mutations in of the ABCR gene in Italian patients with Stargardt disease. |
--- |
| 97 |
2008 |
Correlation of visual function impairment and OCT findings in patients with Stargardt disease and fundus flavimaculatus. |
BCVA, FFM, OCT |
| 98 |
2008 |
Evaluation of macular abnormalities in Stargardt's disease using optical coherence tomography and scanning laser ophthalmoscope microperimetry. |
BCVA, SLO |
| 99 |
2008 |
Evaluation of the common variants of the ABCA4 gene in families with Stargardt disease and autosomal recessive retinitis pigmentosa. |
RP |
| 100 |
2008 |
Evidence of widespread retinal dysfunction in patients with stargardt disease and morphologically unaffected carrier relatives. |
CS, LSF, mfERG |
|
A Search Service for Abbreviation / Long Form
